Inhibikase Therapeutics IKT Institutional Ownership

NASDAQ IKT

$1.66 -0.05 (-2.92%)

At close: Oct 21, 2026 · 4:00 PM EDT

Institutions by Trading Activity

106 Institutions

Increased 68 64.2%

Unchanged 16 15.1%

Reduced 22 20.8%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

68.70%

▲+2.54 pp QoQ

Shares Held by Institutions

119.93Mn

of 174.57Mn outstanding

▲+5.21% QoQ

Shares Outstanding

174.57Mn

54.64Mn held outside 13F filers

Institutional Investors

106

filed 13F for Jun 2026

▲+2 vs prior quarter

Net Shares Added (QoQ)

+5.94Mn

accumulated since last quarter

Value of Holdings

$205.08Mn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Updated Oct 10, 2026

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) was held by 106 institutional investors that filed 13F reports for the quarter ended June 30, 2026.

Their combined stake equaled 68.70% of outstanding shares in Q2 2026, up from 66.16% in Q1 2026.
Total shares held in Inhibikase Therapeutics rose 5.21% versus Q1 2026, while the number of holders rose 125.53% versus Q2 2025.
Of the 106 holders, 68 added to their positions, 22 reduced their stakes and 16 left their positions unchanged in Q2 2026.
The aggregate institutional position in Inhibikase Therapeutics was 119.93Mn shares at the end of Q2 2026, up 5.94Mn from the prior quarter and up 65.52Mn from a year earlier.
As of June 30, 2026, the biggest holder of Inhibikase Therapeutics was Sands Capital Alternatives, LLC with 13.02Mn shares, or 7.46% of shares outstanding.
Holders that added the most shares of Inhibikase Therapeutics in Q2 2026 were Stonepine Capital Management, LLC (+1.51Mn shares), BlackRock, Inc. (+1.46Mn shares), Kalehua Capital Management LLC (+1.15Mn shares), Millennium Management LLC (+1.1Mn shares) and Trails Edge Capital Partners, LP (+993.97K shares).
On the other side, among holders that kept a position in Inhibikase Therapeutics, the largest reductions in Q2 2026 came from Citadel Advisors LLC (-1.03Mn shares), Squadron Capital Management LLC (-500K shares), Bank of America Corp (-214.68K shares), Goldman Sachs Group Inc (-99.69K shares) and Morgan Stanley (-50.25K shares).
Per Business Quant data, the 10 largest holders of Inhibikase Therapeutics at the end of Q2 2026 were Sands Capital Alternatives, LLC (13.02Mn shares), Soleus Capital Management, L.P. (10.88Mn shares), Trails Edge Capital Partners, LP (9.05Mn shares), Fairmount Funds Management LLC (8.62Mn shares), BlackRock, Inc. (7.77Mn shares), ADAR1 Capital Management, LLC (7.39Mn shares), Blackstone Inc. (5.94Mn shares), Siren, L.L.C. (5.85Mn shares), Commodore Capital LP (5.4Mn shares) and Vanguard Capital Management LLC (4.94Mn shares).

Form 13F Holdings

106 Institutional Holders

Report period 30 Jun, 2026

Total shares held 119.93Mn

Of outstanding 68.70%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	Sands Capital Alternatives, LLC	0001846444	13,018,965	7.46%	0	0.00%	$26.43Mn
2	Soleus Capital Management, L.P.	0001802630	10,875,000	6.23%	0	0.00%	$22.08Mn
3	Trails Edge Capital Partners, LP	0002077247	9,051,318	5.18%	▲993,973	+12.34%	$18.37Mn
4	Fairmount Funds Management LLC	0001802528	8,625,000	4.94%	0	0.00%	$17.51Mn
5	BlackRock, Inc.	0002012383	7,768,057	4.45%	▲1,464,624	+23.24%	$15.77Mn
6	ADAR1 Capital Management, LLC	0001940272	7,387,205	4.23%	▲780,633	+11.82%	$15.00Mn
7	Blackstone Inc.	0001393818	5,938,276	3.40%	0	0.00%	$12.05Mn
8	Siren, L.L.C.	0002005245	5,850,000	3.35%	0	0.00%	$11.88Mn
9	Commodore Capital LP	0001831942	5,397,488	3.09%	0	0.00%	$10.96Mn
10	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	4,935,354	2.83%	▲484,689	+10.89%	$10.02Mn
11	MILLENNIUM MANAGEMENT LLC	0001273087	4,028,102	2.31%	▲1,100,025	+37.57%	$8.18Mn
12	Saturn V Capital Management LP	0001964437	3,869,056	2.22%	▲5,611	+0.15%	$7.85Mn
13	Kalehua Capital Management LLC	0002106181	3,821,890	2.19%	▲1,149,282	+43.00%	$7.76Mn
14	Spruce Street Capital LP	0002050194	3,581,603	2.05%	0	0.00%	$7.27Mn
15	Squadron Capital Management LLC	0002050709	3,000,000	1.72%	▼500,000	-14.29%	$6.09Mn
16	Nantahala Capital Management, LLC	0001472322	2,701,863	1.55%	0	0.00%	$5.48Mn
17	GEODE CAPITAL MANAGEMENT, LLC	0001214717	2,607,129	1.49%	▲436,943	+20.13%	$5.29Mn
18	Stonepine Capital Management, LLC	0001440771	2,468,595	1.41%	▲1,511,393	+157.90%	$2.38Mn
19	State Street Corp	0000093751	1,909,101	1.09%	▲223,285	+13.24%	$3.88Mn
20	SummitTX Capital, L.P.	0002052310	1,780,262	1.02%	▲255,726	+16.77%	$3.61Mn

Showing 1 to 20 of 106 holders